Harvard Bioscience Ownership | Who Owns Harvard Bioscience?


OverviewForecastRevenueFinancialsChartTranscripts

Harvard Bioscience Ownership Summary


Harvard Bioscience is owned by 26.12% institutional investors, 8.54% insiders, and 65.35% retail investors. Amh equity is the largest institutional shareholder, holding 9.14% of HBIO shares. Harvey Partners Small-Cap Opportunity is the top mutual fund, with 4.42% of its assets in Harvard Bioscience shares.

HBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHarvard Bioscience26.12%8.54%65.35%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryMedical Instruments & Supplies Stocks31.73%13.63%54.64%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Amh equity4.05M9.14%$1.77M
Blackrock2.84M6.55%$8.10M
Harvey partners2.05M4.63%$898.92K
Vanguard group1.92M4.32%$1.29M
Acadian asset management1.77M3.98%$1.18M
Renaissance1.02M2.29%$683.01K
Meros investment management, lp918.26K2.07%$402.70K
Blackrock funding, inc. /de622.30K1.40%$416.19K
Granahan investment management603.52K1.36%$264.64K
Nano cap new millennium growth fund l p600.00K1.35%$401.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Amh equity4.05M2.21%$1.77M
Nano cap new millennium growth fund l p600.00K0.34%$401.28M
Williams & novak348.80K0.18%$233.28K
Meros investment management, lp918.26K0.17%$402.70K
Harvey partners2.05M0.08%$898.92K
Clarivest asset management114.27K0.03%$325.67K
Triton wealth management, p13.41K0.03%$44.26K
Granahan investment management603.52K0.01%$264.64K
Abel hall37.33K0.01%$16.57K
Corsair capital management100.00K0.01%$43.85K

Top Buyers

HolderShares% AssetsChange
Acadian asset management1.77M0.00%702.94K
Nano cap new millennium growth fund l p600.00K0.34%600.00K
Amh equity4.05M2.21%538.83K
Jane street group415.16K-374.60K
Two sigma investments, lp474.16K0.00%276.37K

Top Sellers

HolderShares% AssetsChange
Royce & associates lp---1.78M
B. riley asset management---1.35M
Boothbay fund management---1.15M
Heartland advisors---1.11M
Granahan investment management603.52K0.01%-897.99K

New Positions

HolderShares% AssetsChangeValue
Nano cap new millennium growth fund l p600.00K0.34%600.00K$401.28M
Corsair capital management100.00K0.01%100.00K$43.85K
Abel hall37.33K0.01%37.33K$16.57K
Susquehanna group, llp35.46K-35.46K$74.81K
Cubist systematic strategies14.14K0.00%14.14K$40.31K

Sold Out

HolderChange
Ifp advisors-15.00
Capital performance advisors llp-41.00
True wealth design-56.00
Ronald blue trust-78.00
Smartleaf asset management-174.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202541-30.51%11,637,146-30.00%261.85%2011.11%10-60.00%
Sep 30, 202558-6.45%16,593,159-10.92%372.12%18-41.94%24-
Jun 30, 202565-27.78%18,909,639-26.25%421.26%3310.00%25-34.21%
Mar 31, 20252-97.89%3,715,394-87.95%80.17%--100.00%2-91.67%
Dec 31, 202445-52.63%15,332,661-50.99%350.68%26-42.22%8-70.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Harvey Partners Small-Cap Opportunity1.97M4.42%-52.56K
Vanguard US Total Market Shares ETF1.26M2.86%-
Vanguard Total Stock Mkt Idx Inv1.23M2.76%-
Heartland Value Investor937.14K2.12%-171.43K
Acuitas US Microcap Strategy910.00K2.03%227.15K
Royce Micro-Cap Trust Inc860.63K1.95%-11.42K
Royce Micro Cap Trust860.63K1.95%-11.42K
Royce Micro-Cap Invmt638.54K1.44%-8.48K
JNL Multi-Manager Small Cap Growth A433.80K0.98%-20.00K
Granahan SC Advantage433.80K0.98%-20.00K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 13, 2024Green James W Chief Executive OfficerBuy$29.10K
Jun 06, 2024Green James W Chief Executive OfficerBuy$61.40K
Aug 17, 2023Green James W Chief Executive OfficerBuy$109.50K
Mar 14, 2023EDRICK ALAN I-Buy$36.87K
Mar 15, 2023EDRICK ALAN I-Buy$42.42K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q22-

HBIO Ownership FAQ


Who Owns Harvard Bioscience?

Harvard Bioscience shareholders are primarily institutional investors at 26.12%, followed by 8.54% insiders and 65.34% retail investors. The average institutional ownership in Harvard Bioscience's industry, Medical Instruments & Supplies Stocks, is 31.73%, which Harvard Bioscience falls below.

Who owns the most shares of Harvard Bioscience?

Harvard Bioscience’s largest shareholders are Amh equity (4.05M shares, 9.14%), Blackrock (2.84M shares, 6.55%), and Harvey partners (2.05M shares, 4.63%). Together, they hold 20.32% of Harvard Bioscience’s total shares outstanding.

Does Blackrock own Harvard Bioscience?

Yes, BlackRock owns 6.55% of Harvard Bioscience, totaling 2.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.1M$. In the last quarter, BlackRock increased its holdings by 9.99K shares, a 0.35% change.

Who is Harvard Bioscience’s biggest shareholder by percentage of total assets invested?

Amh equity is Harvard Bioscience’s biggest shareholder by percentage of total assets invested, with 2.21% of its assets in 4.05M Harvard Bioscience shares, valued at 1.77M$.

Who is the top mutual fund holder of Harvard Bioscience shares?

Harvey Partners Small-Cap Opportunity is the top mutual fund holder of Harvard Bioscience shares, with 4.42% of its total shares outstanding invested in 1.97M Harvard Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools